Home › Employers › Zydus Pharmaceuticals USA, Inc.
Zydus Pharmaceuticals USA, Inc.: H-1B salaries and sponsorship
Zydus Pharmaceuticals USA, Inc. filed 14 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 14. Median offered salary: $132,242.
Does Zydus Pharmaceuticals USA, Inc. sponsor H-1B visas?
Zydus Pharmaceuticals USA, Inc. filed 14 labor condition applications in fiscal years 2023–2026, the latest submitted on May 14, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Analyst Regulatory Affairs | 2 | $92,000 |
| Senior Manager, Regulatory Affairs & Supply Chain | 1 | $158,250 |
| Senior Manager, Regulatory Affairs | 1 | $158,250 |
| Supply Chain Analyst | 1 | $70,100 |
| Director, IT | 1 | $207,675 |
| Senior Analyst, Medicaid & Government Pricing | 1 | $88,200 |
| Manager, Regulatory Affairs | 1 | $112,000 |
| Manager, Accounts Payable | 1 | $137,000 |
| Drug Safety Associate | 1 | $115,000 |
| IT Business Analyst | 1 | $150,000 |
| IT Infrastructure & Security Manager | 1 | $150,000 |
| Director, Regulatory Affairs & Supply Chain | 1 | $203,148 |
| Financial Manager | 1 | $127,483 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 4 | $158,250 |
| FY2024 | 4 | $104,500 |
| FY2025 | 2 | $101,000 |
| FY2026 | 4 | $150,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
- Regulatory Affairs Managers4
- Computer and Information Systems Managers2
- Regulatory Affairs Specialists2
- Industrial Engineers1
- Management Analysts1
- Accountants and Auditors1
- Chemists1
- Data Scientists1
- Financial Managers1
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Financial Manager | $127,483 Level I | Pennington, NJ | May 14, 2026 | Oct 1, 2026 | Certified |
| Director, Regulatory Affairs & Supply Chain | $203,148 Level III | Pennington, NJ | Apr 7, 2026 | Oct 1, 2026 | Certified |
| IT Infrastructure & Security Manager | $150,000 Level I | Pennington, NJ | Apr 3, 2026 | May 1, 2026 | Certified |
| IT Business Analyst | $150,000 Level II | Pennington, NJ | Mar 4, 2026 | Mar 10, 2026 | Certified |
| Senior Analyst Regulatory Affairs | $87,000 Level II | Pennington, NJ | May 30, 2025 | Oct 1, 2025 | Certified |
| Drug Safety Associate | $115,000 Level II | Pennington, NJ | Apr 7, 2025 | Oct 1, 2025 | Certified |
| Manager, Accounts Payable | $137,000 Level III | Pennington, NJ | Aug 5, 2024 | Sep 17, 2024 | Certified |
| Senior Analyst, Medicaid & Government Pricing | $88,200 Level II | Pennington, NJ | May 24, 2024 | Oct 1, 2024 | Certified |
| Manager, Regulatory Affairs | $112,000 Level I | Pennington, NJ | Apr 25, 2024 | Sep 12, 2024 | Certified |
| Senior Analyst Regulatory Affairs | $97,000 Level III | Pennington, NJ | Apr 12, 2024 | Sep 12, 2024 | Certified |
| Supply Chain Analyst | $70,100 Level I | Pennington, NJ | Aug 9, 2023 | Oct 1, 2023 | Certified |
| Director, IT | $207,675 Level III | Pennington, NJ | Jul 12, 2023 | Aug 31, 2023 | Certified |
| Senior Manager, Regulatory Affairs & Supply Chain | $158,250 Level II | Pennington, NJ | Apr 10, 2023 | Oct 1, 2023 | Certified |
| Senior Manager, Regulatory Affairs | $158,250 Level II | Pennington, NJ | Apr 3, 2023 | Oct 1, 2023 | Certified, then withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).